Zhejiang Huahai Gains MEDSAFE and HDEC Approval for HB0043 Phase I Trial
China-based Zhejiang Huahai Pharmaceutical Co., Ltd (SHA: 600521) announced that it has received approval from...
Bayer’s Eylea 8 mg Close to EU Approval for Longer Treatment Intervals
German pharmaceutical giant Bayer (ETR: BAYN) announced that the European Medicines Agency’s (EMA) Committee for...
Sichuan Kelun-Biotech Finalizes Licensing Deal for TSLP Monoclonal Antibody
China-based Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd (HKG: 6990) announced that it has received the upfront...
Roche’s Itovebi Recommended for EU Approval in PIK3CA-Mutated Breast Cancer
Swiss giant Roche AG (SWX: ROG, OTCMKTS: RHHBY) announced that its Itovebi (inavolisib) has been...
Jenscare Announces Positive 30-Day Results for LuX-Valve Plus in TRINITY Study
Ningbo-based structural heart disease device manufacturer Jenscare Scientific Co., Ltd (HKG: 9877) has announced the...
Roche Partners with Broad Clinical Labs to Advance SBX Sequencing Technology
Swiss giant Roche AG (SWX: ROG, OTCMKTS: RHHBY) announced last week a strategic partnership with...
Grand Pharma’s GPN01768 Approved in Macau for Demodectic Blepharitis
Grand Pharmaceutical Group Co., Ltd. (HKG: 0512) announced that its New Drug Application (NDA) for...
Medtronic’s Prevail DCB Gains CE Mark for Expanded Coronary Disease Indications
US-Irish firm Medtronic (NYSE: MDT) announced that its Prevail paclitaxel-coated percutaneous transluminal coronary angioplasty (PTCA)...
Tonghua Dongbao to Sell Stake in Amoytop Biotech for USD 181 Million
Chinese pharmaceutical firm Tonghua Dongbao Pharmaceuticals Co., Ltd (SHA: 600867) has announced plans to divest...
Shandong Boan Biotechnology Partners with HKUST for Biomedicine Innovation
China-based Shandong Boan Biotechnology Co., Ltd (HKG: 6955) has entered into a partnership with the...
PacBio Appoints Haorui Gene as Official Distributor in China
US-based sequencing solutions provider PacBio (NASDAQ: PACB) has appointed China’s Haorui Gene as an official...
Zhongsheng Pharma’s Anruiwei Receives NMPA Approval for Influenza A
China-based Guangdong Zhongsheng Pharmaceutical Co., Ltd (SHE: 002317) announced that it has received marketing approval...
CARsgen’s Satri-Cel Shows Significant Efficacy in Gastric Cancer Study
China-based CARsgen Therapeutics Holdings Limited (HKG: 2171) announced that it has published an abstract of...
Viz.ai Partners with Sanofi and Regeneron to Deploy AI Solution for COPD
US-based Viz.ai this week announced a multi-year partnership with France-based Sanofi (NASDAQ: SNY) and US-based...
GSK’s Nucala Receives FDA Approval for COPD Treatment
UK-based pharmaceutical giant GlaxoSmithKline (GSK, NYSE: GSK) announced that it has received marketing approval from...
Merck’s Welireg Launched in China for Rare Genetic Disorder Treatment
US-based Merck, Sharp & Dohme (MSD; NYSE: MRK) announced the commercial launch of its hypoxia-inducible...
NMPA Approves Bayer/Regeneron’s Eylea HD for Wet AMD Treatment
China’s National Medical Products Administration (NMPA) has approved Bayer (ETR: BAYN) and Regeneron’s (NASDAQ: REGN)...
Ascentage Pharma to Present Data on Lisaftoclax and Alrizomadlin at ASCO 2025
China-based Ascentage Pharma (NASDAQ: AAPG, HKG: 6855) will present the latest data from two ongoing...
Meinian Onehealth Partners with Alibaba DAMO Academy for AI-Driven Disease Screening
China-based Meinian Onehealth Healthcare (Group) Co., Ltd (SHE: 002044) has entered into a partnership with...
Lead Healthcare Raises RMB 100M in Angel Financing to Boost AI-Driven Life Science Instruments
China-based Lead Healthcare Technology (Guangzhou) Co., Ltd reportedly raised close to RMB 100 million (USD...